Explanation
BACKGROUND: Columbus Public Health has been awarded a grant from the Ohio Department of Health. This ordinance is needed to accept and appropriate a total of $45,559.98 in grant money to fund the Enhanced Gonococcal Isolate Surveillance Project (eGISP) Grant Program, for the period of August 1, 2020 through July 31, 2021.
Through increased laboratory and surveillance capacity, participation in the eGISP program will permit Columbus Public Health (CPH) to increase our detection of antibiotic-resistant N. gonorrhoeae (in other words, antibiotic-resistant gonorrhea infection) in our jurisdiction. This program is part of the US government’s “National Strategy for Combating Antibiotic-Resistant Bacteria” and supports the US Center for Disease Control and Prevention (CDC) “Antibiotic Resistance Solutions Initiative.” Examination of samples from gonorrhea-infected clients seeking screening for sexually transmitted diseases in the CPH Sexual Health clinic will be sent to CDC for antibiotic susceptibility testing. Results are combined with findings from other geographical sites across the US to create a current profile of the emergence of antibiotic-resistant gonorrhea. Results are also shared with surveillance and clinical experts at CPH who can make locally-relevant decisions about patient treatment.
This ordinance is submitted as an emergency so as to allow the financial transaction to be posted in the city's accounting system as soon as possible. Up to date financial posting promotes accurate accounting and financial management.
FISCAL IMPACT: The eGISP Grant Program is entirely funded by the Ohio Department of Health.
Title
To authorize and direct the Board of Health to accept a grant from the Ohio Department of Health to fund the Enhanced Gonococcal Isolate Surveillance Project (eGISP) Grant Program; to authorize the appropriation of $45,559.98 from the unappropriated balance of the Health Department Grants Fund; and to declare an eme...
Click here for full text